Education Blog for Healthcare Professionals

Archive for the ‘Guideline’ Category

Bleeding on Antithrombotics: Reversal Protocol 2016

| Bleeding, Guideline | Comments Off

Stephan Moll, MD writes…  Our medical center (University of North Carolina Hospitals,  Chapel Hill)  has put together a comprehensive ”Emergent Anticoagulation Reversal Guideline” for our local use, updated since its last edition in 2014 with information about Pradaxa® reversal (with Praxbind®).  It is  a practical, clinical how-to document (2016 PDF here ). Colleagues and hospitals are welcome to take the document,  modify it, and apply it to their institution – there are no copyright concerns.


Disclosures: I have been a consultant on one occasion for Boehringer-Ingelheim.

Last updated: May 11th, 2016

ACCP Guideline for DVT and PE Treatment: New Edition, 2016

| Anticoagulants, Aspirin, Plavix, Aggrenox, Persantine, Edoxaban, Eliquis, Guideline, Pradaxa (dabigatran), Therapy, Xarelto (Rivaroxaban) | Comments Off

The ACCP Chest Guidelines have been the main guide over the last more than 2 decades for evidence-based recommendations on best management of anticoagulants for various indications, including DVT and PE.  The 10th edition of the chapter on DVT and PE management was published in Jan 2016 [ref 1]. Unfortunately, the guideline is not available for non-subscribers. Read the rest of this entry »

VTE Prophylaxis in Hospitalized Patients: Guidance Document

| Guideline, Prevention | Comments Off

Stephan Moll, MD writes (on 12/5/2014)… Venous thromboembolism (VTE) prophylaxis in hospitalized patients is important; it is also mandated by the Joint Commission [ref].  We have developed at the University of North Carolina (UNC) a guidance document (link here; UNC VTE prophylaxis guidance document) as a resource for our health care professionals to assist in making evidence-based decisions on which patients to give what type of VTE prophylaxis.

Recommendations provided in this document are a reflection of current guidelines, clinical evidence, and UNC institutional initiatives, but are not intended to replace clinical judgment or patient evaluation.  Readers are welcome to use this document for their institution or practice – using it as is or modifying it.


Joint Commission VTE measures (link here)

Disclosures: None

Last updated: Dec 5th, 2014

Difficulty in Diagnosing Recurrent DVT – Clinical Guidance

| Diagnosis, Guideline | Comments Off

Stephan Moll, MD writes….  Recurrent DVT can be challenging to diagnose, as it may be difficult on Doppler ultrasound to tell chronic changes from additional new clot.  A guidance statement from the ISTH (International Society for Thrombosis and Haemostasis) published this week (May 18th, 2013) provides solid, clinically useful, evidence-based recommendations Read the rest of this entry »

ACCP 2012 Guidelines: A Great, New, User-Friendly Summary

| Guideline | Comments Off

Stephan Moll, MD writes…  The more than 20 chapters and 801 pages of the respected 2012 ACCP Antithrombotic Therapy Guidelines – beautifully evidence-based, but always very cumbersome to read for the clinician looking for quick management guidance -, have now been summarized by the ACCP into a visually appealing, uncluttered, clinician-user-friendly document, referred to as “ACCP 2012 Reference Guide” (link to it here).  This was a much-needed development.  The only thing missing now is that one can buy this (90 page summary) as a hard copy for even better, i.e. quicker reference.  This is a highly recommended document for anybody involved in clinical decision-making in regard to antithrombotics in patients at risk for or with established arterial or venous thromboembolism. A very nice, new resource. Read the rest of this entry »